期刊文献+

中西医结合治疗膝关节骨性关节炎40例临床观察 被引量:22

Clinical Observation on Knee Osteoarthritis with Integrated Traditional and Western Medicine
下载PDF
导出
摘要 目的观察中西医结合治疗膝关节骨性关节炎(KOA)的临床疗效。方法将符合诊断标准的80例患者计算机随机数字表法分为两组,每组40例。治疗组采用综合疗法,在口服西药的基础上联合应用针刺与口服独活寄生汤加减治疗,对照组40例则单用西药治疗,评价两组治疗后的临床疗效。结果两组病例治疗后疗效比较差异有统计学意义(P<0.05)。两组病例治疗后疼痛及日常生活评分与本组治疗前比较明显降低,差异有统计学意义(P<0.05);与对照组治疗后比较,治疗组治疗后疼痛及日常生活评分明显降低,差异有统计学意义(P<0.05)。结论中西结合治疗膝关节骨性关节炎总体疗效显著,值得临床应用和推广。 Objective To observe the clinical efficacy on knee osteoarthritis( KOA) with integrated traditional and western medicine. Methods 80 patients were conformed to the diagnostic criteria were divided into two group with 40 patients in each group in accordance with the random number table. Control group was treated with western medicine and the treatment group was given with acupuncture and Duhuojisheng decoction based on control group. The clinical efficacy was evaluated before and after treatment. Results There was statistically meaning between the two groups after treatment in clinical efficacy( P < 0. 05). Compared with the before treatment,the scores of pain and daily life were reduced between two group after treatment( P< 0. 05),but the reduction of treatment group was obvious( P < 0. 05). Conclusion The clinical efficacy on knee osteoarthritis with integrated traditional and western medicine is significant and is worth to applying to the clinic.
出处 《世界中西医结合杂志》 2016年第9期1261-1264,共4页 World Journal of Integrated Traditional and Western Medicine
关键词 膝关节骨性关节炎 针刺 中药 中西医结合 Knee osteoarthritis Acupuncture Herb Integrated traditional and western medicine
  • 相关文献

参考文献3

二级参考文献34

  • 1顾明士,杨军,金哲峰,李绍峙,张金伟,王文彬,周国本.社区中老年人膝骨关节炎发病趋势的分析[J].中医药临床杂志,2005,17(3):246-247. 被引量:23
  • 2张乃峥,施全胜,张雪哲,沙力进,王永和,赵淑霞,芦世华,于桂兰,屈辉.膝骨关节炎的流行病学调查[J].中华内科杂志,1995,34(2):79-83. 被引量:359
  • 3Sharma L. The role of proprioceptive deficits, ligamentous laxity, and malalignment in development and progression of knee osteoarthritis[J]. J Rheumatol Suppl, 2004,70:87-92.
  • 4Baker K, McAlindon T. Exercise for knee osteoarthritis[J]. Curr Opin Rheumatol, 2000, 12(5):456- 463.
  • 5Bellamy N, Kirwan J, Boers M, et al. Recommendations for a core set outcome measure for future phase III clinical trials in knee, hip and hand OA[J]. J Rheumatol, 1997,24:799-802.
  • 6Boers M, Brooks P, Strand VC, et al. The OMERACT filter for outcome measures in rheumatology Editorial [J].J Rheumatol, 1998,25 :198-199.
  • 7Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC; a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee[J]. J Rheumatol, 1988,15:1833- 1840.
  • 8Bellamy N, Buchanan WW, Goldmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically-impor tant patient relevant outcomes following total hip or knee arthroplas ty in osteoarthritis[J].J Orthop Rheumatol, 1988,1 : 95- 108.
  • 9Baron G, Tubach F, Ravaud P, et al. Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis [J]. Arthritis Rheum,2007,57 (4) : 633-638.
  • 10McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) : a review of its utility and measurement properties[J].Arthritis Care Res, 2001, 45:453-461.

共引文献309

同被引文献263

引证文献22

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部